314 related articles for article (PubMed ID: 7914115)
1. [Proxodolol--a new beta- and alpha-adrenoblockader].
Iuzhakov SD; Dolgun OV; Dorodnikova EV; Aniukhovskiĭ EP; Baldenkov GN; Rozenshtraukh LV; Medvedev OS; Mashkovskiĭ MD
Eksp Klin Farmakol; 1994; 57(3):30-3. PubMed ID: 7914115
[TBL] [Abstract][Full Text] [Related]
2. [The effect of proxodolol on systemic and regional hemodynamics].
Dolgun OV; Martynova ER; Medvedev OS; Iuzhakov SD
Eksp Klin Farmakol; 1994; 57(3):33-6. PubMed ID: 7914116
[TBL] [Abstract][Full Text] [Related]
3. [The pharmacodynamic and hypotensive efficacy of proxodolol in an acute drug test on hypertension patients].
Kukes VG; Starodubtsev AK; Smirnov MV; Petrov IN
Eksp Klin Farmakol; 1994; 57(3):45-7. PubMed ID: 7914120
[TBL] [Abstract][Full Text] [Related]
4. [A search for new beta-adrenoblockaders in the series of 5-phenoxymethyl-1,2,4-oxadiazole derivatives].
Mashkovskiĭ MD; Iuzhakov SD
Eksp Klin Farmakol; 1994; 57(3):27-30. PubMed ID: 7914114
[TBL] [Abstract][Full Text] [Related]
5. [The efficacy of proxodolol, a new beta-adrenoblockader with alpha-adrenoblockader properties, in its single use in patients with stable stenocardia of effort].
Metelitsa VI; Martsevich SIu; Kozyreva MP; Slastnikova ID; Vakulovskaia MK
Eksp Klin Farmakol; 1994; 57(3):47-50. PubMed ID: 7914121
[TBL] [Abstract][Full Text] [Related]
6. [Search for new beta-adrenoblockaders among derivatives of (3-amino-2-hydroxypropoxy) phenoxymethyl isoxazole].
Iuzhakov SD; Sokolov SD; Vinogradova SM
Farmakol Toksikol; 1988; 51(4):47-52. PubMed ID: 2903834
[TBL] [Abstract][Full Text] [Related]
7. [A clinico-pharmacological study of an ophthalmic drug form of proxodolol].
Ermakova VN
Eksp Klin Farmakol; 1994; 57(3):57-9. PubMed ID: 7914124
[TBL] [Abstract][Full Text] [Related]
8. [The new Russian preparation proxodolol in the treatment of arterial hypertension].
Ol'binskaia LI; Morozova TE
Eksp Klin Farmakol; 1994; 57(3):42-5. PubMed ID: 7914119
[TBL] [Abstract][Full Text] [Related]
9. Comparative effects of beta-, alpha- and combined beta- plus alpha-adrenoceptor blocking agents in stress-induced increase in arterial blood pressure.
Pandhi P; Sharma PL
Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):297-300. PubMed ID: 2887519
[TBL] [Abstract][Full Text] [Related]
10. [Beta-adrenoblocking activity and other pharmacological properties of 2-(3-amino-2-hydroxypropoxy)phenyoxymethyl isoxazole derivatives].
Iuzhakov SD; Zaĭtseva KA; Dorodnikova EV; Mashkovskiĭ MD
Farmakol Toksikol; 1985; 48(3):36-40. PubMed ID: 2863169
[TBL] [Abstract][Full Text] [Related]
11. [The efficacy of proxodolol in patients with stable arterial hypertension].
Metelitsa VI; Ostrovskaia TP; Duda SG; Shastun RS; Chel'dieva EIa; Simonov DV; Kalinin AL; Kekshina MS
Eksp Klin Farmakol; 1994; 57(3):38-42. PubMed ID: 7914118
[TBL] [Abstract][Full Text] [Related]
12. The properties of beta-adrenoceptor antagonists.
Shanks RG
Postgrad Med J; 1976; 52 Suppl 4():14-20. PubMed ID: 9628
[TBL] [Abstract][Full Text] [Related]
13. Current status of labetalol, the first alpha- and beta-blocking agent.
Kanto JH
Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):617-28. PubMed ID: 2867049
[TBL] [Abstract][Full Text] [Related]
14. Extremely long-acting antihypertensive effects of KF-4317, a alpha- and beta 1-adrenoceptor blocker.
Kubo K; Ikeda J; Nakamura J; Nakamizo N
Arch Int Pharmacodyn Ther; 1985 Sep; 277(1):140-60. PubMed ID: 2865934
[TBL] [Abstract][Full Text] [Related]
15. Antihypertensive actions of an isomer of labetalol and other vasodilator-beta-adrenoceptor blockers.
Baum T; Sybertz EJ
Fed Proc; 1983 Feb; 42(2):176-81. PubMed ID: 6130003
[TBL] [Abstract][Full Text] [Related]
16. Effects of the R, R-isomer of labetalol, SCH 19927, in isolated tissues and in spontaneously hypertensive rats during a repeated treatment.
Monopoli A; Bamonte F; Forlani A; Ongini E; Parravicini L
Arch Int Pharmacodyn Ther; 1984 Dec; 272(2):256-63. PubMed ID: 6151824
[TBL] [Abstract][Full Text] [Related]
17. Combined alpha- and beta-adrenoceptor blocking drug AH 5158: further studies on alpha-adrenoceptor blockade in anaesthetized animals.
Kennedy I; Levy GP
Br J Pharmacol; 1975 Apr; 53(4):585-92. PubMed ID: 238705
[TBL] [Abstract][Full Text] [Related]
18. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of rats. Part A.
Wiśniewska RJ
Pol J Pharmacol; 1998; 50(3):203-12. PubMed ID: 9861628
[TBL] [Abstract][Full Text] [Related]
19. Alpha and beta adrenoceptor blocking properties of labetalol and its R,R-isomer, SCH 19927.
Sybertz EJ; Sabin CS; Pula KK; Vliet GV; Glennon J; Gold EH; Baum T
J Pharmacol Exp Ther; 1981 Aug; 218(2):435-43. PubMed ID: 6114171
[TBL] [Abstract][Full Text] [Related]
20. Bufuralol, a new beta-adrenoceptor blocking agent in a series of benzofuran-2-ethanolamines. Part 2: pharmacology.
Hamilton TC; Parkes MW
Arzneimittelforschung; 1977 Jul; 27(7):1410-7. PubMed ID: 20114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
